Mukundan Hari, Mukherjee Deboleena, Tyagi Kirti, Taneja Sachin, Ranjan Subhash, Sahu Samaresh
Senior Advisor (Radiotherapy) & Head, Radiotherapy Centre, Command Hospital (Air Force), Bengaluru 560007, India.
Medical Physicist, Radiation Oncology Centre, INHS Asvini, Colaba, Mumbai 400005, India.
Med J Armed Forces India. 2020 Jan;76(1):51-57. doi: 10.1016/j.mjafi.2018.07.008. Epub 2018 Oct 15.
Inaccuracies in treatment setup during radiation therapy for breast cancers may increase risks to surrounding normal tissue toxicities, i.e. organs at risks (OARs), and compromise disease control. This study was planned to evaluate the dosimetric and isocentric variations and determine setup reproducibility and errors using an online electronic portal imaging (EPI) protocol.
A total of 360 EPIs in 60 patients receiving breast/chest wall irradiation were evaluated. Cumulative dose-volume histograms (DVHs) were analyzed for mean doses to lung (V20) and heart (V30), setup source to surface distance (SSD) and central lung distance (CLD), and shifts in anterior-posterior (AP), superior-inferior (SI), and medial lateral (ML) directions.
Random errors ranged from 2 to 3 mm for the breast/chest wall (medial and lateral) tangential treatments and 2-2.5 mm for the anterior supraclavicular nodal field. Systematic errors ranged from 3 to 5 mm in the AP direction for the tangential fields and from 2.5 to 5 mm in the SI and ML direction for the anterior supraclavicular nodal field. For right-sided patients, V20 was 0.69-3.96 Gy, maximum lung dose was 40.5 Gy, V30 was 1.4-3 Gy, and maximum heart dose was 50.5 Gy. Similarly, for left-sided patients, the CLD (treatment planning system) was 25 mm-30 mm, CLD (EPIs) was 30-40 mm, V20 was 0.9-5.9 Gy, maximum lung dose was 45 Gy, V30 was 2.4-4.1 Gy, and maximum heart dose was 55 Gy.
Online assessment of patient position with matching of EPIs with digitally reconstructed radiographs (DRRs) is a useful method in evaluation of interfraction reproducibility in breast irradiation.
乳腺癌放射治疗期间治疗摆位不准确可能会增加周围正常组织毒性(即危及器官,OARs)的风险,并影响疾病控制。本研究旨在使用在线电子射野影像(EPI)方案评估剂量学和等中心变化,并确定摆位的可重复性和误差。
对60例接受乳腺/胸壁照射的患者共360幅EPI进行了评估。分析累积剂量体积直方图(DVH),以获取肺(V20)和心脏(V30)的平均剂量、摆位源皮距(SSD)和中心肺距离(CLD),以及前后(AP)、上下(SI)和内外(ML)方向的位移。
乳腺/胸壁(内侧和外侧)切线野治疗的随机误差范围为2至3毫米,前锁骨上淋巴结野为2至2.5毫米。切线野在AP方向的系统误差范围为3至5毫米,前锁骨上淋巴结野在SI和ML方向的系统误差范围为2.5至5毫米。对于右侧患者,V20为0.69至3.96 Gy,最大肺剂量为40.5 Gy,V30为1.4至3 Gy,最大心脏剂量为50.5 Gy。同样,对于左侧患者,CLD(治疗计划系统)为25毫米至30毫米,CLD(EPI)为30至40毫米,V20为0.9至5.9 Gy,最大肺剂量为45 Gy,V30为2.4至4.1 Gy,最大心脏剂量为55 Gy。
通过将EPI与数字重建射线影像(DRR)匹配对患者体位进行在线评估,是评估乳腺照射分次间可重复性的一种有用方法。